Equivalent price position
Unlock the full competitive price benchmark
See the exact peer median, min/max and quartiles, product rank, price percentile and the complete like-for-like competitor table.
Price-position comparison uses current official listed prices normalized to compatible units. It is a price benchmark, not a measure of sales, demand, prescription volume or market share.
Product details
- Generic
- Losartan
- Therapeutic area
- Cardiovascular
- Drug class
- Angiotensin II receptor blockers
- ATC
- C09CA01
- Strength
- 50 mg
- Dosage form
- Tablet
- Pack
- 2*10,s
- Registration no.
- 053684
- Price record verified
- 2026-08-08
- Latest DRAP source check
- 2026-10-09 03:22
Manufacturer
MS SIZA INTERNATIONAL PVT LTD.
Explore this manufacturer's complete MedInfoBase portfolio, generics and current listed prices.
View company portfolio →About KALSARTAN -H 50 mg tablet
KALSARTAN -H 50 mg tablet contains Losartan 50 mg. It is registered with DRAP by MS SIZA INTERNATIONAL PVT LTD (registration no. 053684). Its official price is PKR 611.31 for a pack of 2*10,s. This price has applied since 27 July 2026. 68 other brands of Losartan 50 mg (tablet) are registered in Pakistan. Compare all brands and prices →
Other brands of Losartan 50 mg
Official price over time
No change in the official DRAP price is recorded for this pack (2*10,s). Current price PKR 611.31, effective 27 Jul 2026.
Cite this price history
MedInfoBase. KALSARTAN -H 50 mg, 2*10,s: official price history (source: DRAP PharmaPrice Index). https://medinfobase.com/brand/kalsartan-h-50-mg-053684-210s-ms-siza-international-pvt-ltd/ (accessed 9 October 2026).
Official price history
| Amount | Effective from | Verified | Source | Status |
|---|---|---|---|---|
| PKR 611.31 | 2026-07-27 | 2026-09-22 | DRAP PharmaPrice Index (recovered from snapshot #84) | Current |
Other listed brands
Cite this record
Medicine record · DRAP registration 053684Price and registration data on this page were observed on 22 September 2026. Records change over time, so please cite the observation date alongside the access date.
